Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)Jan B. Vermorken, Paul M. Clément, Éva Remenár et al.|Annals of Oncology|2014Cited by 95
Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: The ADVANTAGE phase II trial.Jan B. Vermorken, Paul M. Clément, Frédéric Peyrade et al.|Journal of Clinical Oncology|2012Cited by 7